2013
Goto M, Ishikawa Y, Sugimoto M, Furuichi Y.
Werner syndrome: a changing pattern of clinical manifestations in Japan (1917~2008). Biosci Trends. 7, 13-22. 2013.
2012
Miyamoto M, Furuichi Y, Komiyama T.
The high-osmolarity glycerol- and cell wall integrity-MAP kinase pathways of Saccharomyces cerevisiae are involved in adaptation to the action of killer toxin HM-1. Yeast. 29, 475-485. 2012.
Goto M, Sugimoto K, Hayashi S, Ogino T, Sugimoto M, Furuichi Y, Matsuura M, Ishikawa Y, Iwaki-Egawa S, Watanabe Y.
Aging-associated inflammation in healthy Japanese individuals and patients with Werner syndrome. Exp Gerontol. 47, 936-939. 2012.
Kubota N, Inayoshi Y, Satoh N, Fukuda T, Iwai K, Tomoda H, Kohara M, Kataoka K, Shimamoto A, Furuichi Y, Nomoto A, Naganuma A, Kuge S.
HSC90 is required for nascent hepatitis C virus core protein stability in yeast cells. FEBS Lett. 586, 2318-2325. 2012.
De S, Kumari J, Mudgal R, Modi P, Gupta S, Futami K, Goto H, Lindor NM, Furuichi Y, Mohanty D, Sengupta S.
RECQL4 is essential for the transport of p53 to mitochondria in normal human cells in the absence of exogenous stress. J Cell Sci. 125, 2509-2522. 2012.
Takada-Watanabe A, Yokote K, Takemoto M, Fujimoto M, Irisuna H, Honjo S, Futami K, Furuichi Y, Saito Y.
A case of Werner syndrome without metabolic abnormality: implications for the early pathophysiology. Geriatr Gerontol Int. 12, 140-146. 2012.
2011
Kabir ME, Karim N, Krishnaswamy S, Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.
Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal
agent compared to its parent fungicide HM-1 killer toxin peptide. Appl Microbiol Biotechnol. 92, 1151-1160. 2011.
Rahman MM, Kabir ME, Krishnaswamy S, Miyamoto M, Furuichi Y, Komiyama T.
New avenues for phage-display library to produce a Cryptococcus-specific anti-idiotypic antibody of HM-1 killer toxin. J Mol Recognit. 24, 631-641. 2011.
Sugimoto M, Furuichi Y, Ide T, Goto M.
Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (Review). Oncol Lett. 2, 609-611. 2011.
Kabir ME, Krishnaswamy S, Miyamoto M, Furuichi Y, Komiyama T.
An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent. Appl Microbiol Biotechnol. 90, 553-564. 2011.
Krishnaswamy S, Kabir ME, Rahman MM, Miyamoto M, Furuichi Y, Komiyama T.
Isolation and characterization of recombinant single chain fragment variable anti-idiotypic antibody specific to Aspergillus fumigatus membrane protein. J Immunol Methods. 366, 60-68. 2011.
Arai A, Chano T, Futami K, Furuichi Y, Ikebuchi K, Inui T, Tameno H, Ochi Y, Shimada T, Hisa Y, Okabe H.
RECQL1 and WRN Proteins Are Potential Therapeutic Targets in Head and Neck Squamous Cell Carcinoma. Cancer Res. 71, 4598-4607. 2011.
2010
Kataoka K, Kono Y, Sugtimoto M, Furuichi Y, Shichiri M, Tanaka Y.
Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic hepatitis C and murine acute hepatocyte disorder. Exp Ther Med. 1, 1041. 2010.
Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y.
RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.Int J Mol Med. 25, 537. 2010.
2009
Kabir ME, Krishnaswamy S, Miyamoto M, Furuichi Y, Komiyama T.
An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody. BMC Biotechnol. 9, 99. 2009. [Epub ahead of print]
Krishnaswamy S, Kabir ME, Miyamoto M, Furuichi Y, Komiyama T.
Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution. Anal Biochem. 395, 16-24, 2009.
Abe T, Goda K, Futami K, Furuichi Y.
Detection of siRNA administered to cells and animals by using a fluorescence intensity distribution analysis polarization system. Nucleic Acids Res. 37, e56, 2009.
Futami K, Furuichi Y.
Quantitation of full-size small interfering RNA by tailing with terminal deoxynucleotidyl transferase and reverse transcription-polymerase chain reaction analysis. Anal Biochem. 385, 386-388, 2009.
Iso T, Futami K, Iwamoto T, Furuichi Y.
Effects of estrogenic agents 17β-Estradiol (E2) and bisphenol A on the expression of RecQ DNA helicases in mammary tumorMCF-7 cells. J Health Sci. 55, 119-124, 2009.
2008
Hirose K, Wakashin H, Oki M, Kagami S, Suto A, Ikeda K, Watanabe N, Iwamoto I, Furuichi Y, Nakajima H.
GS143, an IkappaB ubiquitination inhibitor, inhibits allergic airway inflammation in mice. Biochem Biophys Res Commun. 374, 507-511, 2008.
Futami K, Kumagai E, Makino H, Sato A, Takagi M, Shimamoto A, Furuichi Y.
Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci. 99, 1227-1236, 2008.
Izumikawa K, Yanagida M, Hayano T, Tachikawa H, Komatsu W, Shimamoto A, Futami K, Furuichi Y, Shinkawa T, Yamauchi Y, Isobe T, Takahashi N.
Association of human DNA helicase RecQ5beta with RNA polymerase II and its possible role in transcription. Biochem J. 413, 505-516, 2008.
Futami K, Ishikawa Y, Goto M, Furuichi Y, Sugimoto M.
Role of WRN helicase in carcinogenesis and in resistance by cancer cells to genotoxins. Cancer Sci. 99, 843-848, 2008.
Nakajima H, Fujiwara H, Furuichi Y, Tanaka K, Shimbara N.
A novel small-molecule inhibitor of NF-kappaB signaling. Biochem Biophys Res Commun. 368, 1007-1013, 2008.
Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto A, Furuichi Y.
Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Cancer Sci. 99, 71-80, 2008.
2007
Futami K, Takagi M, Shimamoto A, Sugimoto M, Furuichi Y.
Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase. Biol Pharm Bull. 30, 1958-1961, 2007.
Futami K, Shimamoto A, Furuichi Y.
Mitochondrial and Nuclear localization of human Pif1 helicase. Biol Pharm Bull. 30, 1685-1692, 2007.
Oishi M, Nagasaki Y, Nishiyama N, Itaka K, Takagi M, Shimamoto A, Furuichi Y, Kataoka K.
Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes. ChemMedChem. 2, 1290-1297, 2007.
Iso T, Futami K, Iwamoto T, Furuichi Y.
Modulation of the Expression of Bloom Helicase by Estrogenic Agents. Biol Pharm Bull. 30, 266-271, 2007.
2006
Shibata S, Sasaki M, Miki T, Shimamoto A, Furuichi Y, Katahira J, Yoneda Y.
Exportin-5 orthologues are functionally divergent among species. Nucleic Acids Res. 34, 4711-4721, 2006.
Woo LL, Futami K, Shimamoto A, Furuichi Y, Frank KM.
The Rothmund-Thomson Gene, RECQL4, localized to the nucleolus in response to oxidative stress. Exp Cell Res. 312, 3443-3457, 2006.
Selvakumar D, Karim N, Miyamoto M, Furuichi Y, Komiyama T.
Recombinant single-chain anti-idiotypic antibody: an effective fungal beta-1,3-glucan synthase inhibitor. Biol Pharm Bull. 29,1848-1853, 2006.
Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.
Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies. Antimicrob Agents Chemother. 50, 3090-3097, 2006.
Goto M, Okawa-Takatsuji M, Aotsuka S, Nakai H, Shimizu M, Goto H, Shimamoto A, Furuichi Y.
Significant elevation of IgG anti-WRN (RecQ3 RNA/DNA helicase) antibody in systemic sclerosis. Mod Rheumatol. 16, 229-234, 2006.
Kawabe Y, Seki M, Yoshimura A, Nishino K, Hayashi T, Takeuchi T, Iguchi S, Kusa Y, Ohtsuki M, Tsuyama T, Imamura O, Matsumoto T, Furuichi Y, Tada S, Enomoto T.
Analyses of the interaction of WRNIP1 with Werner syndrome protein (WRN) in vitro and in the cell. DNA Repair (Amst). 5, 816-828, 2006.
Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.
Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies. J Antibiot (Tokyo). 59, 73-79, 2006.
Selvakumar D, Zhang QZ, Miyamoto M, Furuichi Y, Komiyama T.
Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin. J Biochem. 139, 399-406, 2006.
Iso T, Watanabe T, Iwamoto T, Shimamoto A, Furuichi Y.
DNA damage caused by bisphenol A and estradiol through estrogenic activity. Biol Pharm Bull. 29, 206-210, 2006.
2005
Sawada K, Noda K, Nakajima H, Shimbara N, Furuichi Y, Sugimoto M.
Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines. Biol Pharm Bull. 28, 1202-1207, 2005.
Miyamoto M, Han GD, Kimura T, Furuichi Y, Komiyama T.
Alanine-scanning mutagenesis of HM-1 killer toxin and the essential residues for killing activity. J Biochem. 137, 517-22. 2005.
Takahashi M, Okada J, Ito K, Hashimoto M, Hashimoto K, Yoshida Y, Furuichi Y, Ohta Y, Mishiro S, Gemma N.
Construction of an electrochemical DNA chip for simultaneous genotyping of single nucleotide polymorphisms. Analyst. 130, 687-93. 2005.
Sengupta S, Shimamoto A, Koshiji M, Pedeux R, Rusin M, Spillare EA, Shen JC, Huang LE, Lindor NM, Furuichi Y, Harris CC.
Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene 24, 1738-48, 2005.
Futami K, Goto H, Shimamoto A, Watanabe T, Furuichi Y.
Quantitative analysis of Werner helicase activity by using the single-molecule fluorescence detection system MF10S. Biol Pharm Bull. 28, 9-12, 2005.
|
